These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid. Tapani S; Almquist J; Leander J; Ahlström C; Peletier LA; Jirstrand M; Gabrielsson J J Pharm Sci; 2014 Aug; 103(8):2571-84. PubMed ID: 24986056 [TBL] [Abstract][Full Text] [Related]
11. Acute dose-dependent disposition studies of nicotinic acid in rats. Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575 [TBL] [Abstract][Full Text] [Related]
12. Selectivity of action of 8-alkylamino analogues of N6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats. van Schaick EA; Tukker HE; Roelen HC; IJzerman AP; Danhof M Br J Pharmacol; 1998 Jun; 124(3):607-18. PubMed ID: 9647488 [TBL] [Abstract][Full Text] [Related]
13. Challenging the dose-response-time data approach: Analysis of a complex system. Andersson R; Jirstrand M; Almquist J; Gabrielsson J Eur J Pharm Sci; 2019 Feb; 128():250-269. PubMed ID: 30453011 [TBL] [Abstract][Full Text] [Related]
14. A novel minimal model to describe non-esterified fatty acid kinetics in Holstein dairy cows. Boston RC; Roche JR; Ward GM; Moate PJ J Dairy Res; 2008 Feb; 75(1):13-8. PubMed ID: 17922935 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a compartmental model to describe non-esterified fatty acid kinetics in Holstein dairy cows. Moate PJ; Roche JR; Chagas LM; Boston RC J Dairy Res; 2007 Nov; 74(4):430-7. PubMed ID: 17651516 [TBL] [Abstract][Full Text] [Related]
16. Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers. Yassen A; Olofsen E; Romberg R; Sarton E; Teppema L; Danhof M; Dahan A Clin Pharmacol Ther; 2007 Jan; 81(1):50-8. PubMed ID: 17185999 [TBL] [Abstract][Full Text] [Related]
17. A novel minimal model to describe NEFA kinetics following an intravenous glucose challenge. Boston RC; Moate PJ Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1140-7. PubMed ID: 18234748 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat. Miyazaki M; Maekawa C; Iwanaga K; Morimoto K; Kakemi M Biol Pharm Bull; 2000 Nov; 23(11):1363-9. PubMed ID: 11085367 [TBL] [Abstract][Full Text] [Related]
19. Physiological indirect effect modeling of the antilipolytic effects of adenosine A1-receptor agonists. van Schaick EA; de Greef HJ; Ijzerman AP; Danhof M J Pharmacokinet Biopharm; 1997 Dec; 25(6):673-94. PubMed ID: 9697077 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats. Lee DS; Kim SJ; Choi GW; Lee YB; Cho HY Molecules; 2018 Apr; 23(4):. PubMed ID: 29662027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]